253 related articles for article (PubMed ID: 28862321)
1. Expression of HLA-DRA and CD74 mRNA in whole blood during the course of complicated and uncomplicated Staphylococcus aureus bacteremia.
Rasmussen G; Cajander S; Bäckman A; Källman J; Söderquist B; Strålin K
Microbiol Immunol; 2017 Oct; 61(10):442-451. PubMed ID: 28862321
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Real-Time Polymerase Chain Reaction Measurement of HLA-DRA Gene Expression in Whole Blood Is Highly Reproducible and Shows Changes That Reflect Dynamic Shifts in Monocyte Surface HLA-DR Expression during the Course of Sepsis.
Cajander S; Tina E; Bäckman A; Magnuson A; Strålin K; Söderquist B; Källman J
PLoS One; 2016; 11(5):e0154690. PubMed ID: 27144640
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
Trials; 2019 May; 20(1):250. PubMed ID: 31046810
[TBL] [Abstract][Full Text] [Related]
4. Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response: A diagnostic tool for immunosuppression?
Winkler MS; Rissiek A; Priefler M; Schwedhelm E; Robbe L; Bauer A; Zahrte C; Zoellner C; Kluge S; Nierhaus A
PLoS One; 2017; 12(8):e0182427. PubMed ID: 28771573
[TBL] [Abstract][Full Text] [Related]
5. Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients.
Pachot A; Monneret G; Brion A; Venet F; Bohé J; Bienvenu J; Mougin B; Lepape A
Crit Care Med; 2005 Jan; 33(1):31-8; discussion 236-7. PubMed ID: 15644645
[TBL] [Abstract][Full Text] [Related]
6. Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.
Chong YP; Moon SM; Bang KM; Park HJ; Park SY; Kim MN; Park KH; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
Antimicrob Agents Chemother; 2013 Mar; 57(3):1150-6. PubMed ID: 23254436
[TBL] [Abstract][Full Text] [Related]
7. Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.
Sharma-Kuinkel BK; Wu Y; Tabor DE; Mok H; Sellman BR; Jenkins A; Yu L; Jafri HS; Rude TH; Ruffin F; Schell WA; Park LP; Yan Q; Thaden JT; Messina JA; Fowler VG; Esser MT
J Clin Microbiol; 2015 Jan; 53(1):227-36. PubMed ID: 25392350
[TBL] [Abstract][Full Text] [Related]
8. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.
Brown PJ; Wong KK; Felce SL; Lyne L; Spearman H; Soilleux EJ; Pedersen LM; Møller MB; Green TM; Gascoyne DM; Banham AH
Leukemia; 2016 Mar; 30(3):605-16. PubMed ID: 26500140
[TBL] [Abstract][Full Text] [Related]
9. Decreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shock.
Cazalis MA; Friggeri A; Cavé L; Demaret J; Barbalat V; Cerrato E; Lepape A; Pachot A; Monneret G; Venet F
Crit Care; 2013 Dec; 17(6):R287. PubMed ID: 24321376
[TBL] [Abstract][Full Text] [Related]
10. Australian Group on Antimicrobial Resistance Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2014.
Coombs GW; Daley DA; Thin Lee Y; Pearson JC; Robinson JO; Nimmo GR; Collignon P; Howden BP; Bell JM; Turnidge JD;
Commun Dis Intell Q Rep; 2016 Jun; 40(2):E244-54. PubMed ID: 27522136
[TBL] [Abstract][Full Text] [Related]
11. Human genetic variation in GLS2 is associated with development of complicated Staphylococcus aureus bacteremia.
Scott WK; Medie FM; Ruffin F; Sharma-Kuinkel BK; Cyr DD; Guo S; Dykxhoorn DM; Skov RL; Bruun NE; Dahl A; Lerche CJ; Petersen A; Larsen AR; Lauridsen TK; Johansen HK; Ullum H; Sørensen E; Hassager C; Bundgaard H; Schønheyder HC; Torp-Pedersen C; Østergaard LB; Arpi M; Rosenvinge F; Erikstrup LT; Chehri M; Søgaard P; Andersen PS; Fowler VG
PLoS Genet; 2018 Oct; 14(10):e1007667. PubMed ID: 30289878
[TBL] [Abstract][Full Text] [Related]
12. Increased overall survival after introduction of structured bedside consultation in Staphylococcus aureus bacteraemia.
Ariaans MBPA; Roovers EA; Claassen MAA; Hassing RJ; Swanink CMA; Gisolf EH
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1187-1193. PubMed ID: 29671174
[TBL] [Abstract][Full Text] [Related]
13. Complement levels in patients with bloodstream infection due to Staphylococcus aureus or Gram-negative bacteria.
Eichenberger EM; Dagher M; Ruffin F; Park L; Hersh L; Sivapalasingam S; Fowler VG; Prasad BC
Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2121-2131. PubMed ID: 32621149
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase MMP-8, TIMP-1 and MMP-8/TIMP-1 ratio in plasma in methicillin-sensitive Staphylococcus aureus bacteremia.
Forsblom E; Tervahartiala T; Ruotsalainen E; Järvinen A; Sorsa T
PLoS One; 2021; 16(5):e0252046. PubMed ID: 34043679
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 2 downregulation and cytokine dysregulation predict mortality in patients with Staphylococcus aureus bacteremia.
Kim NH; Sung JY; Choi YJ; Choi SJ; Ahn S; Ji E; Kim M; Kim CJ; Song KH; Choe PG; Park WB; Kim ES; Park KU; Kim NJ; Oh MD; Kim HB
BMC Infect Dis; 2020 Nov; 20(1):901. PubMed ID: 33256638
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus-induced complement activation promotes tissue factor-mediated coagulation.
Skjeflo EW; Christiansen D; Fure H; Ludviksen JK; Woodruff TM; Espevik T; Nielsen EW; Brekke OL; Mollnes TE
J Thromb Haemost; 2018 May; 16(5):905-918. PubMed ID: 29437288
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of monocytic HLA-DR expression differs between bacterial etiologies during the course of bloodstream infection.
Cajander S; Rasmussen G; Tina E; Magnuson A; Söderquist B; Källman J; Strålin K
PLoS One; 2018; 13(2):e0192883. PubMed ID: 29466395
[TBL] [Abstract][Full Text] [Related]
18. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
Kaasch AJ; Fätkenheuer G; Prinz-Langenohl R; Paulus U; Hellmich M; Weiß V; Jung N; Rieg S; Kern WV; Seifert H;
Trials; 2015 Oct; 16():450. PubMed ID: 26452342
[TBL] [Abstract][Full Text] [Related]
19. Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia.
Rose WE; Shukla SK; Berti AD; Hayney MS; Henriquez KM; Ranzoni A; Cooper MA; Proctor RA; Nizet V; Sakoulas G
Clin Infect Dis; 2017 May; 64(10):1406-1412. PubMed ID: 28205673
[TBL] [Abstract][Full Text] [Related]
20. The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia.
Pérez-Rodríguez MT; Sousa A; Moreno-Flores A; Longueira R; Diéguez P; Suárez M; Lima O; Vasallo FJ; Álvarez-Fernández M; Crespo M
Int J Infect Dis; 2021 Jan; 102():554-560. PubMed ID: 33157291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
